Lalazar, Gadi

Publishing since 2006 (Baby)

Has published 16 publications in 5 years

Number of publications published per year by Lalazar, Gadi. (Source : PubMed)

Distribution of publications types for Lalazar, Gadi. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Ilan Y, Zigmond E, Lalazar G, Dembinsky A, Ben Ya'acov A, Hemed N, Kasis I, Axelrod E, Zolotarov L, Klein A, El Haj M, Gandhi R, Baecher-Allan C, Wu H, Murugaiyan G, Kivisakk P, Farez MF, Quintana FJ, Khoury SJ, Weiner HL. Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells.  J. Clin. Immunol.  2010;30;1  
•  Lalazar G, Ben Ya'acov A, Livovsky DM, El Haj M, Pappo O, Preston S, Zolotarov L, Ilan Y. Beta-glycoglycosphingolipid-induced alterations of the STAT signaling pathways are dependent on CD1d and the lipid raft protein flotillin-2.  Am. J. Pathol.  2009;174;4  
•  Lalazar G, Adar T, Ilan Y. Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial.  World J. Gastroenterol.  2009;15;8  
•  Zigmond E, Zangen SW, Pappo O, Sklair-Levy M, Lalazar G, Zolotaryova L, Raz I, Ilan Y. Beta-glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat.  Am. J. Physiol. Endocrinol. Metab.  2009;296;1  
•  Lalazar G, Pappo O, Hershcovici T, Hadjaj T, Shubi M, Ohana H, Hemed N, Ilan Y. A continuous 13C methacetin breath test for noninvasive assessment of intrahepatic inflammation and fibrosis in patients with chronic HCV infection and normal ALT.  J. Viral Hepat.  2008;15;10  
•  Adar T, Rubinger D, Lalazar G, Levi L, Mizrahi M, Bogot RN. [Nephrogenic systemic fibrosis]  Harefuah  2008;147;10  
•  Lalazar G, Ben Ya'acov A, Eliakim-Raz N, Livovsky DM, Pappo O, Preston S, Zolotarov L, Ilan Y. Beta-glycosphingolipids-mediated lipid raft alteration is associated with redistribution of NKT cells and increased intrahepatic CD8+ T lymphocyte trapping.  J. Lipid Res.  2008;49;9  
•  Mizrahi M, Lalazar G, Ben Ya'acov A, Livovsky DM, Horowitz Y, Zolotarov L, Adler R, Shouval D, Ilan Y. Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination.  Vaccine  2008;26;21  
•  Mizrahi M, Lalazar G, Horwich Y, Adar T, Safadi R. [Benign recurrent intrahepatic cholestasis type-II--a rare cause of direct hyperbilirubinemia exacerbations with hepatic fibrosis]  Harefuah  2008;147;5  
•  El Haj M, Ya'acov AB, Lalazar G, Ilan Y. Potential role of NKT regulatory cell ligands for the treatment of immune mediated colitis.  World J. Gastroenterol.  2007;13;44  

[ See timeline ] [ See all publications ]